Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Don S.Boller who wrote (29092)	7/21/1999 6:43:00 PM
From: Skeeter Bug	Respond to of 32384

don, i've owned lgnd off and on for 2-3 years. i see lots of potential. i've seen a few management gaffes, but nothing too severe nor really unexpected. i currently own a lot of lgndw and hope lgnd can be up 23% instead of down 23% very soon ;-) however, my hopes and a nickel are worth about a nickel. the truth is the truth. i'm not spinning, just commenting that the stock performance has been dismal during the greatest of bull markets. that is a fact. i'm not selling b/c i feel it is undervalued. i just wish others would agree w/ my sense of value. they may have to get hit over the head with profits first. ps - past dismal performance is not a guarantee of future dismal performance ;-)

To: Don S.Boller who wrote (29092)	7/21/1999 8:44:00 PM
From: Wallace Rivers	Read Replies (1) \| Respond to of 32384

**OTNo, I'm long, I do see potential in the company, but that doesn't mean I have to agree with every positive post here. I think the thread title is unnecessary and sounds of hyperbole, as I've said many times before - can't we make our own judgments whether the stock is or isn't "Breaking Out!"? "Naysayers" aren't the only ones guilty of name calling, and the mere fact that some are given such a title (it's happened numerous times) is in itself "name calling". I posted facts** about the performance of LGND versus a very popular and well followed biotech index showing that it had underperformed, and in a post shortly thereafter, it was mentioned that some used "slanted data". If that was in reference to my comparisons, the only thing that was "slanted" or wrong might be the figures of the BTK index, which were eyeballed, as I don't have tick by tick daily historical data on them, or my math.